Tag: ACC.21
ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in...
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as an adjunctive therapy after lower extremity revascularisation to reduce first and subsequent...
